S212-0260 Screening compound: N~1~-(2-furylmethyl)-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]tetrahydro-1(2H)-pyridinecarboxamide

S212-0260 Screening compound: N~1~-(2-furylmethyl)-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]tetrahydro-1(2H)-pyridinecarboxamide
S212-0260 Screening compound: N~1~-(2-furylmethyl)-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]tetrahydro-1(2H)-pyridinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S212-0260
N~1~-(2-furylmethyl)-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]tetrahydro-1(2H)-pyridinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S212-0260

Molecular Formula

C15H20N4O4 (C15 H20 N4 O4)

Compound Name

N~1~-(2-furylmethyl)-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]tetrahydro-1(2H)-pyridinecarboxamide

IUPAC name

n/a

SMILES

Cc1noc(COC(CCC2)CN2C(NCc2ccco2)=O)n1

InChI

InChI=1S/C15H20N4O4/c1-11-17-14(23-18-11)10-22-13-4-2-6-19(9-13)15(20)16-8-12-5-3-7-21-12/h3,5,7,13H,2,4,6,8-10H2,1H3,(H,16,20)/t13-/m0/s1

InChI Key

FTCUZHPMBLHUJT-ZDUSSCGKSA-N

MDL Number (MFCD)

MFCD29031840

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

320.35

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.143

Distribution Coefficient, logD

1.143

Water Solubility, LogSw

-1.72

Polar Surface Area

72.681

Acid Dissociation Constant (pKa)

14.33

Base Dissociation Constant (pKb)

0.77

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

53.30

S212-0260 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S212-0260 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S212-0260?
Check Price and Availability of S212-0260, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S212-0260 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S212-0260
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S212-0260
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S212-0260 available by request